Skip to main content

Table 3 Symptoms and treatments in the year after PICU discharge in 39 children by ARDS type

From: Whole pulmonary assessment 1 year after paediatric acute respiratory distress syndrome: prospective multicentre study

  p-ARDS n = 31 ep-ARDS n = 8 p value
Time after discharge (year) 1.06 (1–1.11) 1.05 (0.94–1.11) 0.75
Respiratory symptoms at rest, exercise, maintenance treatment 23 (74.2%) 1 (12.5%) 0.0026
Chronic cough 5 (16.1%) 0 0.56
Wheezing episodes 16 (51.6%) 0 0.012
 A least 3 wheezing episodes 10 (32.3%) 0 NA
Lower respiratory tract infection 11 (35.5%) 0 0.078
 A least 3 episodes 3 (9.7%) 0 NA
Maintenance respiratory treatment 19 (63.3%) 0 0.003
 Inhaled glucocorticosteroids 16 (51.6%) 0 0.012
 Inhaled long-acting β2-agonists 7 (22.6%) 0 0.31
 Inhaled rapid-acting β2-agonists 14 (45.2%) 0 0.034
 Inhaled rapid-acting atropinic 1 (3.2%) 0 NA
 Leukotriene modifier 2 (6.5%) 0 NA
 Oxygen therapy 1 (3.2%) 0 NA
 Course of systemic glucocorticosteroids in the year 4 (12.9%) 0 NA
 Antibiotics 9 (29.0%) 0 0.16
  1. ep-ARDS extra-pulmonary ARDS, p-ARDS pulmonary ARDS. Results are medians (interquartile ranges) for quantitative variables, and frequencies and percentages for categorical variables